Abstract
The serum and glucocorticoid inducible protein kinase (SGK) family signals downstream of phosphoinositide-3-kinase (PI3K) and is made up of three isoforms: SGK1, 2, and 3. respectively, and their activity is dependent on growth factor activation. Among these SGK families, one such potential target and a less explored enzyme is SGK3. SGK3 regulates a range of basic cellular processes, such as cell proliferation, migration and survival, thus playing an important role in cancer development. These kinase-signaling pathways present both opportunities and challenges for cancer therapy. In this paper, we reviewed the status of SGK3 regulation and its role in normal cell physiology and transformation. In addition, the potential roles of SGK3 signal transduction in breast cancer and prostate cancer are discussed.
Keywords: SGK3, AKT, PI3K, INPP4B, mTOR, breast cancer, prostate cancer.
Current Signal Transduction Therapy
Title:Mechanisms of Activation and Key Roles of SGK3 Under Physiological Conditions and in Prostate and Breast Cancer
Volume: 16 Issue: 2
Author(s): Rajesh Basnet*Buddha Bahadur Basnet
Affiliation:
- Chinese Academy of Sciences, Beijing,China
Keywords: SGK3, AKT, PI3K, INPP4B, mTOR, breast cancer, prostate cancer.
Abstract: The serum and glucocorticoid inducible protein kinase (SGK) family signals downstream of phosphoinositide-3-kinase (PI3K) and is made up of three isoforms: SGK1, 2, and 3. respectively, and their activity is dependent on growth factor activation. Among these SGK families, one such potential target and a less explored enzyme is SGK3. SGK3 regulates a range of basic cellular processes, such as cell proliferation, migration and survival, thus playing an important role in cancer development. These kinase-signaling pathways present both opportunities and challenges for cancer therapy. In this paper, we reviewed the status of SGK3 regulation and its role in normal cell physiology and transformation. In addition, the potential roles of SGK3 signal transduction in breast cancer and prostate cancer are discussed.
Export Options
About this article
Cite this article as:
Basnet Rajesh *, Basnet Bahadur Buddha , Mechanisms of Activation and Key Roles of SGK3 Under Physiological Conditions and in Prostate and Breast Cancer, Current Signal Transduction Therapy 2021; 16 (2) . https://dx.doi.org/10.2174/1574362415666200203122829
DOI https://dx.doi.org/10.2174/1574362415666200203122829 |
Print ISSN 1574-3624 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-389X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Bevacizumab and Angiogenesis Inhibitors in the Treatment of CNS Metastases: The Road less Travelled
Current Molecular Pharmacology Natural Products as Anti-Invasive and Anti-Metastatic Agents
Current Medicinal Chemistry Synthesis, Characterization of 4-Anilino-6,7-Dimethoxy Quinazoline Derivatives as Potential Anti-Angiogenic Agents
Anti-Cancer Agents in Medicinal Chemistry Obesity and Asthma
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery Engineered Silver Nanoparticles, A New Nanoweapon Against Cancer
Anti-Cancer Agents in Medicinal Chemistry The Many Faces of MTA3 Protein in Normal Development and Cancers
Current Protein & Peptide Science Multifunctional Nanoparticles, Nanocages and Degradable Polymers as a Potential Novel Generation of Non-Invasive Molecular and Cellular Imaging Systems
Recent Patents on Nanotechnology Infringement of the Barriers of Cancer Via Dietary Phytoconstituents Capsaicin Through Novel Drug Delivery System
Current Drug Delivery Genetics of Bladder Malignant Tumors in Childhood
Current Genomics Impact of Cellular Senescence in Aging and Cancer
Current Pharmaceutical Design Psychopathological Behaviour and Cognition in Morbid Obesity
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery Simultaneous Separation, Quantitation, and Determination of the Dissociation Constant of Five Components of Ixeris sonchifolia by Microemulsion Electrokinetic Chromatography
Current Pharmaceutical Analysis An Update of In Silico Tools for the Prediction of Pathogenesis in Missense Variants
Current Bioinformatics Analysis and Validation of Differentially Expressed MicroRNAs with their Target Genes Involved in GLP-1RA Facilitated Osteogenesis
Current Bioinformatics Potential Anticancer Effect of Carvacrol Codrugs on Human Glioblastoma Cells
Current Drug Delivery Immune Checkpoint Inhibitors: Basics and Challenges
Current Medicinal Chemistry Exciting Potential of Nanoparticlized Lipidic System for Effective Treatment of Breast Cancer and Clinical Updates: A Translational Prospective
Current Pharmaceutical Design DYRK1A Kinase Inhibitors with Emphasis on Cancer
Mini-Reviews in Medicinal Chemistry The First Kinetic Enzymatic Resolution of Methyl Ester of C75
Letters in Organic Chemistry Experimental Methods and Transport Models for Drug Delivery Across the Blood-Brain Barrier
Current Pharmaceutical Biotechnology